Both in Biotechnology
Lexeo Therapeutics vs Lineage Cell Therapeutics
Over the past year LXEO returned −61.3% and LCTX returned −42.8%; their daily moves had a correlation of 0.31.
LXEO −61.3% LCTX −42.8%Growth of $1, one year, split-adjusted
| Metric | LXEO | LCTX |
|---|---|---|
| Price | $3.26 | $1.03 |
| Market cap | $267.2M | $260.5M |
| Today | +4.66% | +1.98% |
| 1 month | −1.4% | +9.8% |
| 6 months | −47.8% | −28.0% |
| Year to date | −67.2% | −38.3% |
| 1 year | −64.0% | −47.4% |
| Revenue growth (YoY) | — | −61.3% |
| Gross margin | — | 100.0% |
| Net margin | — | 138.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 19.9× |
| Net cash | $211.1M | $50.8M |
| Dividend yield | — | — |
| Volatility (60d) | 69.5% | 52.5% |
| Short % of float | 22.9% | 12.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).